Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sulzer Medica IntraCoil Peripheral Stent Approved Despite Panel Reservations

This article was originally published in The Gray Sheet

Executive Summary

Sulzer Medica's Intratherapeutics unit expects sales of the IntraCoil stent to double over the next year, following PMA approval April 8 for primary stenting of the femoral and popliteal arteries

You may also be interested in...



FDA Passes On Critical Limb Ischemia Laser; Spectranetics Ponders Options

Spectranetics hopes FDA will accept a retrospective analysis of bypass surgery data as a control arm to support a critical limb ischemia indication for its CVX-300 excimer laser catheter system in lieu of further clinical studies

FDA Passes On Critical Limb Ischemia Laser; Spectranetics Ponders Options

Spectranetics hopes FDA will accept a retrospective analysis of bypass surgery data as a control arm to support a critical limb ischemia indication for its CVX-300 excimer laser catheter system in lieu of further clinical studies

ev3 Expanding Vascular Presence Via $95 Mil. IntraTherapeutics Acquisition

Private equity investor Warburg Pincus' ev3, Inc. unit is looking to build its peripheral vascular disease business through the purchase of Centerpulse subsidiary IntraTherapeutics for $95 mil. cash

Related Content

UsernamePublicRestriction

Register

MT016422

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel